Basic Clinician Training Module 4 Special circumstances: Distinguishing between different causes of bleeding.

Slides:



Advertisements
Similar presentations
Coagulopathy and blood component transfusion in trauma
Advertisements

Hemostasis Shaina Eckhouse 10/12/2010.
Transfusion in Cardiopulmonary Bypass. Blood Use & Cardiac Surgery 1971 – average 8 units RBC per case Late 1980’s – Texas Heart Institute 1.4 units per.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
Brad Beckham T4. Definitions  Major blood loss Hemoglobin concentration below 6-10 g/dl  Massive transfusion in adults >9 erythrocyte units within 24h.
Massive transfusion: New Protocol
Basic Clinician Training
Blood Components Dosage And Their Administration
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U.
Basic Clinician Training Module 5
An Overview of Hemostasis
Basic Clinician Training Module 7 PlateletMapping™ PlateletMapping™ Assays.
Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
HEMOSTASIS Hemostasis
BLOOD BANKING 1- BLOOD PRODUCTS 2- AUTOLOGOUS TRANSFUSION M. H. Shaheen Maadi Armed Forces Hospital.
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.
MTP Octaplex rFVIIa Calgary. Massive Transfusion Protocol.
TEG® Interpretation Review TRACING BOOTCAMP
Dr MOHAMMED H SAIEMALDAHR FACULTY of Applied Medical Sciences
Preoperative Assessment of Hemostasis Or Stop Doing Bleeding Times! Lt Col Lucia E. More United States Air Force.
Hypercoagulable States Basic Clinician Training Module 4 Introduction Hypercoagulable States Test Your Knowledge.
Basic Clinician Training Module 3
Approach to Bleeding Disorders
Fluids and blood products in trauma
Basic Clinician Training Module 2
HEMOSTASIS Primary hemostasis.
Role of Factor Concentrates in Perioperative Coagulopathies Dr Neville Gibbs Department of Anaesthesia Sir Charles Gairdner Hospital.
Hemostasis. Defined Stopping or arresting the loss of blood or hemorrhage.
Basic Clinician Training Module 6
The Clotting Cascade and DIC Karim Rafaat, MD. Coagulation Coagulation is a host defense system that maintains the integrity of the high pressure closed.
ATH: A Novel Heparin-Based Anticoagulant
Fibrinolysis and Hyperfibrinolysis TEG Analysis
Inherited bleeding disorder of primary hemostasis.
Good Morning 6 June Uremic Bleeding: Pathogenesis and Therapy 麻醉科 林子富.
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
Blood Transfusion Safe Practice.
Von Willebrand’s Disease. vWD Family of bleeding disorders Family of bleeding disorders Caused by a deficiency or an abnormality of von Willebrand Factor.
INHERITED DISORDERS OF COAGULATION von Willebrand Disease 1.
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics Roles Senior clinician Coordinate team and allocate roles Determine volume and type.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
AN APPROACH TO THE ANEMIC PATIENT. Prevalence and causes of anemia world-wide Blood 2014;123:615 Us More common in women Iron deficiency most common cause.
ICU Management of the bleeding surgical patient
Plasma and plasma components in the management of disseminated intravascular coagulation Marcel Levi* Academic Medical Center, University of Amsterdam,
Coagulation and anti-coagulants March Normal physiology Patophysiology Diagnostic tests Anticoagulants Anticoagulants and anesthesia.
Chapter 23. Bleeding disorders associated with coagulopathy
 Disorders of iron metabolism are evaluated primarily by : 1. packed cell volume 2. Hemoglobin & red cell count and indices 3. Total iron and TIBC, percent.
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
R4 서미선 Bleeding in uremia. Introduction  main determinants of uremic bleeding → impaired platelet function  multifactorial  defects intrinsic.
Activation of the Hemostatic System During Cardiopulmonary Bypass
Activation of the Hemostatic System During Cardiopulmonary Bypass
General Approach of Haemostasis
Thrombelastograph® (TEG®) Coagulation Analyzer
General Approach in Investigation of Hemostasis
Diagnosis Approach of Bleeding in Children ________________________________ Ketut Ariawati Hematologi Onkologi RSUP Sanglah Denpasar.
Hemodynamic disorders (1 of 3)
Coagulation Cascade of the Newborn
Benefits of autotransfusion
Anti-Coagulants Physical Process of Clotting
Dr-Majid Qanavat Ped. Hematologist oncologist Isfahan university -1396
Congenital bleeding disorders
Reversal of Direct Oral Anticoagulants (DOAC)
Anticoagulant Reversal
Drugs Affecting Blood.
Perioperative factor concentrate therapy
The child with hematological dysfunction
Blood Components Dosage And Their Administration
Presentation transcript:

Basic Clinician Training Module 4 Special circumstances: Distinguishing between different causes of bleeding

Bleeding: special circumstances Hemodilution vs. Hypothermia von Willebrand factor deficiency vs. Surgical bleeding Protamine overdose

Hemodilution vs. Hypothermia

Hemodilution Implementation Hematocrit < 25% Circumstances: of blood conservation techniques  Blood volume expansion  Cardiopulmonary bypass Likely to affect factors and platelets the same. Hypothermia Core temperature <34°C Circumstances:  Exposure to the cold  Induced for clinical purposes  Administration of large volume of fluids that are cold or at room temperature May not demonstrate same effect on factors and platelets, depends on temperature.

Hemodilution Reduction in the concentration of hemostatic factors and cellular hemostatic components. Hypothermia At 33°C the likely cause of bleeding is a reduction in platelet aggregation and adhesion. At < 33°C the likely cause of bleeding also includes reduced enzymatic function and platelet activation Hemodilution vs. Hypothermia Mechanisms of Coagulapathy [Wolberg AS, et. al. J Trauma. 2004;56:1221.]

Hemodilution vs. Hypothermia Differentiation and Treatments Hemodilution Identification: low HCT, normal temperature Common treatment:  Hemoconcentration, if possible  FFP for factor deficiency  Platelet transfusion for platelet deficiency Hypothermia Identification: Core temperature < 34°C, normal or low HCT. Common treatment:  Warm patient to > 36 ° C  Treat factor deficiency or platelet dysfunction if required (i.e. abnormal TEG tracing at normal temperature setting (37 ° C)).

Run blood sample on two channels simultaneously  Channel 1: cup temperature set at 37°C  Channel 2: adjust cup temperature to patient core temperature Results:  If Channel 1 (37°C) sample is normal and Channel 2 abnormal, bleeding is due to hypothermia and should subside with rewarming.  If both Channel 1 (37°C) and Channel 2 samples demonstrate a coagulapathy, treat with appropriate blood products or hemostatic agents until the 37°C sample is normalized. Hypothermia: Determining impact on coagulation

Black : cup temperature 37°C Green : cup temperature set at patient temperature (33°C) Patient bleeding likely due to hypothermia

Hemodilution vs. Hypothermia TEG analysis Patient status: bleeding Hemodilution vs. Hypothermia? A single TEG tracing cannot distinguish. If patient temperature is > 35°C and HCT < 25%, bleeding is likely due to hemo- dilution. Treat accordingly. If patient temperature is < 34°C, bleeding is likely due to hypothermia. Compare TEGs run at patient temperature and at 37°C. Treat accordingly.

Hemodilution vs. Hypothermia? TEG analysis Cup temperature: 37°C Patient status: bleeding Probable cause(s): Hemodilution +/or Factor deficiency +/or Platelet deficiency/dysfunction

Hemodilution vs. Hypothermia? TEG analysis Cup temperature: 33.4°C Patient status: bleeding Probable cause(s): Hypothermia +/or Factor deficiency +/or Platelet deficiency/dysfunction

vWF deficiency vs. Surgical bleeding

von Willebrand factor (vWF) deficiency vWF  Deficiency is associated with a FVIIIc deficiency  Required for platelet adhesion to vessel wall via the GP1b receptor. Circumstances:  Congential  Acquired Cardiopulmonary bypass Chronic aortic stenosis Malignancy Coagulapathy is due to reduced platelet adhesion to vessel wall, manifested as microvascular bleeding.

vWF deficiency: TEG analysis Patient status: bleeding Since vWF deficiency results in a platelet adhesion defect, the TEG tracing will be normal. Other possible causes of bleeding: Presence of platelet inhibitor Vessel injury

vWF deficiency: TEG analysis Patient status: bleeding Probable causes  Common treatments vWF deficiency  DDAVP Presence of platelet inhibitor  Platelet transfusion Vessel injury  Suture

vWF deficiency vs. Surgical bleeding? Both cases: TEG tracing is normal but patient is bleeding Distinguishing vWF deficiency from surgical bleeding:  vWF deficiency: appears microvascular in nature  Surgical bleeding: generally more profuse and localized Common treatments  vWF deficiency Consider treatment with DDAVP –Diminished bleeding post treatment suggestive of vWF deficiency Consider cryoprecipitate  Surgical bleeding: bleeding from small surgical sites May diminish with time May respond to continuous product transfusion

Protamine overdose

Protamine Neutralizes heparin via an ionic interaction  1 mg protamine neutralizes 1 mg heparin Protamine administration protocols vary. Typical range:  1.0 – 1.3 mg/ 100 units heparin  0.5 – 1.0 mg/kg body wt Protamine alone, or not bound to heparin, has a mild anticoagulant effect

Possible mechanisms of protamine anticoagulant effect. Inhibits the proteolytic activity of thrombin in a dose-dependent and reversible manner Decreases platelet count Impairs in vitro response to ADP, epinephrine, and thrombin Also releases tPA from endothelial cells Speiss, BD et al. Perioperative Transfusion Medicine

Protamine anticoagulation effect Protamine doses > 2.0 mg/100 units heparin could cause bleeding  Clinical significance of protamine anticoagulation effect is debatable Protamine doses between 1.3 – 1.5 mg/100 units heparin may result in an in vitro, but not an in vivo anticoagulant effect.  If the patient is bleeding, this in vitro effect could mask the true cause of bleeding as indicated by TEG analysis. Prudent to avoid administration of protamine doses beyond the amount required neutralize heparin.  TEG analysis can demonstrate heparin reversal by protamine

In vitro protamine effect TEG analysis Post protamine Patient status: not bleeding Protamine dose > 1.3 mg/100 units heparin In vitro effect demonstrated in both Kaolin and Kaolin with heparinase samples

In vitro protamine effect TEG analysis Black: 1 hr post-op Green: post-protamine A TEG was repeated 1 hr post-op in the ICU. The in vitro protamine effect was no demonstrated.

Interpretation Exercises Hemorrhage – Special Cases

Exercise 1: Trauma patient in ER Black: cup 37.1°C Green: cup patient temperature (32.9°C) Using the TEG Decision Tree, what is (are) the possible cause(s) of bleeding in this patient? [Select all that apply] a. Factor deficiency b. Platelet deficiency or dysfunction c. Hypothermia d. Hemodilution e. Anticoagulant effect Answer Next

Exercise 2: Trauma patient in the ER The above patient came into the ER with a core temperature of 35.8°C. The patient has received 2.5 L of crystalloid volume. The patient is now hemodynamically stable, but his core temperature is 34.3°C and he has started to bleed. What would be the best treatment option for this patient at this time to stop the bleeding? a. Lasix b. FFP c. Platelets d. Warm patient to > 35.5°C e. DDAVP What additional information would help you with your decision? Answer Next

Exercise 3 Post-protamine The above 47 yr patient (male, aortic valve replacement) is bleeding after administration of protamine. All suture sites appear to be intact. What is (are) the most likely cause(s) of bleeding in this patient? (select all that apply) a.Surgical bleeding b.Factor deficiency c.Residual platelet inhibitor effect d.Anticoagulant effect e.Diminished platelet adhesion What additional information would help with your decision? Answer Next

Exercise 4 Select all the possible causes of bleeding that could be indicated by the above TEG tracing and indicate an how you could differentiate between the different causes. a.Surgical bleeding b.Factor deficiency c.Platelet dysfunction d.Anticoagulant effect e.Hypothermina cup 37.1°C Answer Next

Exercise 5 Post-protamine, Cup temperature: 37.1°C The above TEG was performed post-protamine. The patient is dry and the surgeon is ready to close the patient. The surgeon has asked for the results of the TEG. How would you explain the above tracing? a.Poor sampling technique or preparation b.Hemodilution c.Hypothermina effect d.Residual heparin e.In vitro protamine effect Answer Next

Exercise 1: Trauma patient in ER Black: cup 37.1°C Green: cup patient temperature (34.6°C) Using the TEG Decision Tree, what is (are) the possible cause(s) of bleeding in this patient? [Select all that apply] a. Factor deficiency – could be result of bleeding plus crystalloid or colloid volume replacement. b. Platelet deficiency or dysfunction – could be result of bleeding plus crystalloid or colloid volume replacement. c. Hypothermia – not a primary cause of bleeding since both cups demonstrate similar coagulapathy. Transfusion of warmed fluids is recommended to diminish further drop in core temperature d. Hemodilution – result of bleeding plus crystalloid or colloid volume replacement leading to factor and platelet deficiency. e. Anticoagulant effect Back Next

Exercise 2: Trauma patient in the ER The above patient came into the ER with a core temperature of 35.8°C. The patient has received 2.5 L of crystalloid volume. The patient is now hemodynamically stable, but his core temperature is 34.3°C and he has started to bleed. What would be the best treatment option for this patient at this time to stop the bleeding? a. Lasix – although the patient may be hemodiluted, it is not the main cause of bleeding. b. Cryoprecipitate c. Platelets d. Warm patient to > 35.5°C – best and least costly treatment option at this time. e. DDAVP – there could be a possible platelet adhesion defect in this patient What additional information would help you with your decision? Run a TEG at 34.3°C to determine if coagulapathy is temperature-related. Back Next

Exercise 3 Post-protamine The above 47 yr patient (male, aortic valve replacement) is bleeding after administration of protamine. All suture sites appear to be intact. What is (are) the most likely cause(s) of bleeding in this patient? (select all that apply) a.Surgical bleeding b.Factor deficiency c.Residual platelet inhibitor effect d.Anticoagulant effect e.Diminished platelet adhesion – this is the most likely cause of bleeding, unless the patient was taking platelet inhibitors for vascular disease. Consider treatment with DDAVP. What additional information would help with your decision? Current medications such as platelet inhibitors, or a family history of vWD. Back Next

Exercise 4 Select all the possible causes of bleeding that could be indicated by the above TEG tracing and indicate a common treatment for each cause. Surgical bleeding Factor deficiency – elongated R suggests factor deficiency. A likely cause is hemodilution. Common treatment: FFP Platelet dysfunction – low MA suggests platelet dysfunction. This could be due to a variety of factors, including hemodilution or a decrease in platelet number due to sequestration or loss of platelets. Common treatment: platelet transfusion Anticoagulant effect – the elongated R also suggests residual heparin, especially since it is a KH sample. Common treatment: protamine Hypothermina – cannot be completely ruled out, but not likely. cup 37.1°C Back Next

Exercise 5 The above TEG was performed post-protamine. The patient is dry and the surgeon is ready to close the patient. The surgeon has asked for the results of the TEG. How would you explain the above tracing? a.Poor sampling technique or preparation – possible, but uncommon cause. b.Hemodilution c.Hypothermina effect d.Residual heparin e.In vitro protamine effect – check with anesthesia for protamine ratio used to reverse the heparin Back Next Post-protamine, Cup temperature: 37.1°C

End of module 4